Absolute Bioavailability of BMS-626529 After Oral and Intravenous Dosing

Clinical trial NCT02805556 · COMPLETED

Trial details

NCT number: NCT02805556
Sponsor: ViiV Healthcare
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2016-03-15
Primary completion: 2016-05-05
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.